UK to resume HCQ trial
Published
Britain’s medical regulatory agency has approved the resumption of a trial testing whether hydroxychloroquine (HCQ), the malaria drug favoured by US President Donald Trump, might help prevent health workers from contracting the novel Coronavirus.
The Medicines and Healthcare Products Regulatory Agency had suspended...